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Abstract
Purpose In previous studies, associations between breast-milk cortisol levels obtained on one occasion and infant neuro-
development were demonstrated. However, more recent evidence indicates that breast-milk cortisol and cortisone con-
centrations follow the diurnal rhythm of maternal hypothalamus-pituitary-adrenal axis, peaking in the early morning and
with a nadir at midnight. We studied associations between breast-milk glucocorticoid (GC) rhythmicity, and infant behavior
and sleep.
Methods We included 59 mothers, and their infants, of whom 17 had consulted an expert center during pregnancy for an
increased risk of psychological distress. At 1 month postpartum, breast milk was sampled (on average six times) over a 24 h
period for assessment of cortisol and cortisone using LC-MS/MS, and experienced maternal distress was assessed using the
Hospital Anxiety and Depression Scale questionnaire. Three months after birth, infant behavior was assessed with the Infant
Behavior Questionnaire, and infant sleep pattern was quantified by questionnaire. Associations between breast-milk GC
rhythm parameters (maximum, delta, and Area Under the Curve increase and ground) and infant behavior and sleep were
tested with linear regression analyses.
Results No consistent associations between breast-milk GC rhythm parameters and infant behavior or sleep were found.
Conclusions Breast-milk GC rhythmicity at 1 month postpartum was not associated with infant behavior or sleep at the age
of 3 months. Findings from previous studies linking breast-milk cortisol to infant neurodevelopment might be biased by the
lack of GC measurements across the full diurnal cycle, and should therefore be interpreted with caution.
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Introduction
Approximately 15% of pregnant women in Western coun-
tries are diagnosed with psychiatric conditions [1].
Depressive and anxiety disorders are associated with
alterations in hypothalamic-pituitary-adrenal (HPA-) axis
activity, such as a lower morning peak or less diurnal
variability in cortisol level [2, 3]. Maternal glucocorticoids
(GCs) crossing the placenta may influence the settings of
the fetal HPA axis, possibly through alterations in the
expression of GC and mineralocorticoid receptors in the
developing hippocampus and amygdala [4]. In humans,
fetal exposure to maternal depression or anxiety symptoms
was associated with a more fearful temperament and dis-
organized sleep, along with a flattened cortisol rhythm,
infancy [5–7]. Studies suggest that such effects may
be mediated by increased fetal exposure to maternal GCs
[8–10].
The development of an adult-type diurnal cortisol
rhythm, characterized by cortisol concentrations that are
higher in the morning than in the evening, is thought to start
at ~1 month of age, and continues to develop during the first
year of life [11]. It has been hypothesized that the devel-
opment of HPA axis rhythmicity may serve as a modulator
for the development of behavioral rhythms, such as the
sleep-wake cycle [12, 13]. Previous research has demon-
strated that a diurnal GC rhythm develops before sleep
rhythmicity is established around the age of 2–4 months
[14, 15]. Multiple factors may be involved in the develop-
ment of HPA axis rhythmicity, such as environmental time
cues (e.g., daylight) and maternal care [15]. In addition, it
has been proposed that non-nutritive bioactive compounds
in breast milk might be involved in the development of
sleep regulation in infants [16].
Animal studies have shown that GCs in breast milk are
able to cross the intestinal wall, and to enter the circula-
tion in offspring [17, 18]. Among Rhesus monkeys, off-
spring exposed to higher levels of breast-milk cortisol
were found to exhibit a more nervous, less confident
behavior and impulsivity, albeit with few differences
between male and female offspring [19–21]. In rats,
exposure to physiological ranges of ingested GCs was
associated with reduction of fearfulness and stress-
induced corticosterone secretion throughout the lifespan
[22]. In breastfed human infants, exposure to maternal
cortisol has also been associated with behavioral out-
comes [23–25]. Two studies showed that higher breast-
milk cortisol was associated with negative affectivity
among girls, but not among boys [24, 26]. Another study
showed that higher plasma cortisol, which has strong
correlation with breast-milk cortisol [27], was associated
with increased infant fear behavior [23]. In contrast,
others found breast-milk cortisol to be unrelated to infant
crying and fussing [28]. However, none of these studies
collected samples multiple times during the day, in spite
of evidence indicating that breast-milk GCs follow the
diurnal rhythm of maternal HPA axis activity [27]. Some
of these studies statistically adjusted for interindividual
differences in sampling time, which assumes that the
cortisol slope barely differs between subjects. However, it
has been demonstrated that post-hoc statistical correction
for sampling time may not be able to provide an adequate
representation of an individual’s HPA-axis dynamics
[27, 29].
The aim of this study was to investigate associations
between exposure to breast-milk GCs over a 24-h period at
1 month postpartum, and infant behavior and sleep at the
age of 3 months. The timing of these assessments was based
on the presumption that HPA axis rhythms in early devel-
opment could guide the development of behavioral
rhythms, an effect that could be tested more reliably at age
3 months when interindividual differences increase [12–15].
In this study, we oversampled mothers at risk of psycho-
logical distress during and after pregnancy in an attempt to
capture a wide range of maternal HPA axis activity, since
depression and anxiety have previously been associated
with GC rhythmicity [2, 3].
Methods
Participants
From March 2016 to July 2017, mothers were approached
within the first days after delivery at the maternity wards
of the Amsterdam University Medical Center, location
VUmc (Group 1, n= 42), and the OLVG hospital (Group
2, n= 17), The Netherlands. Mothers included at the
OLVG hospital had an increased risk of psychological
distress and, therefore, consulted the Psychiatric Obstetric
Pediatric (POP) outpatient clinic during pregnancy.
Breastfeeding mothers of infants born after full-term
gestation (37–42 weeks of pregnancy) with a birth weight
appropriate for gestational age (i.e., between −2 and 2 SD
score) were eligible for inclusion. Exclusion criteria were
preeclampsia/HELLP, multiple pregnancy, consumption
of >7 IU of alcohol per week, fever >38.5 °C at the time of
sampling, and major congenital anomalies. In addition,
mothers who used drugs other than “over the counter”
drugs were excluded, with the exception of Selective
Antidepressants for mothers included at the OLVG hos-
pital. Approval of the Medical Ethics Committee of the
Amsterdam University Medical Center, location VUmc,
was obtained (protocol number 2015.524), and written
informed consent was obtained from all participating
mothers.
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Data collection
Maternal and infant characteristics
During the first days postpartum, maternal and infant
characteristics were obtained by questionnaire. At the time
of the milk collection (at 1 month postpartum), mothers
were asked to fill in the Hospital Anxiety and Depression
Scale (HADS) for assessment of maternal psychological
distress experienced during the preceding 2 weeks [30]. The
HADS contains 14 items, including seven items for
depressive symptoms (Hospital Depression Subscale
[HDS]) and seven items for anxiety symptoms (Hospital
Anxiety Subscale [HAS]). Items are scored as 0–3, and a
score ≥8 on either subscale indicates clinically relevant
depression and/or anxiety symptoms. Accordingly, we
defined increased maternal stress as HDS score and/or HAS
score ≥8.
Breast-milk sample collection
At 30 ± 5 days postpartum, 1–2 mL of breast milk was
collected before every feed over a 24 h period, either
manually or with a breast pump. Mothers were requested to
report the sampling times exactly, since they were breast-
feeding their child on demand. Mothers were asked to
abstain from alcohol at least one day before and during the
milk collection. Following collection, samples were stored in
plastic tubes at −20 °C until they were thawed for analysis.
Infant behavior and sleep
At 3 months (±2 weeks) postpartum, mothers were asked to
fill in the Infant Behavior Questionnaire (IBQ) and a
questionnaire for the quantification of infant sleep. The IBQ
is a validated instrument for the assessment of temperament
in infants aged 3 months to 1 year [31, 32]. The original
IBQ contains 94 items on six scales of temperament
dimensions (distress to limitations, approach to novel sti-
muli, soothability, duration of orienting, smiling and
laughter, and activity) that show considerable stability over
time [33]. The IBQ assesses behavior on a seven-point
Likert scale, with answers ranging from “never” to
“always,” or “does not apply.” To minimize recall bias, the
answers pertain to the infant’s behavior over the preceding
1–2 weeks. The mean scoring represents the outcome for
each dimension separately. The sleep questionnaire (see
Supplementary File 1) included the total hours of night-time
and daytime sleep, the number of daytime naps, and the
number of nights with more than 6 h of consecutive sleep
during 1 week.
Determination of cortisol and cortisone levels in
milk
An isotope dilution liquid chromatography-tandem mass
spectrometry (LC-MS/MS) method was used to assess
cortisol and cortisone concentrations in milk, as described
previously [34]. In short, milk samples were washed with
hexane after adding internal standards to the samples (13C3
labeled cortisol and cortisone). Samples were extracted
using Isolute plates (Biotage, Uppsala, Sweden) and ana-
lyzed by LC-MS/MS (Acquity with Quattro Premier XE,
Milford MA, USA, Waters Corporation). For cortisol, the
intra-assay coefficient of variation (CV) was 4–5%, and for
cortisone it was 5% at different levels. For both cortisol and
cortisone, the interassay CV was <9%, and the Lower Limit
of Quantitation was 0.5 nmol/L.
Data analyses
Breast-milk GC rhythm parameters were recorded over a
24-h period, and were defined as: the maximum con-
centration measured (as a proxy for the peak concentration),
the delta between the maximum and the minimum con-
centration (as a measure of rhythm variability), and the area
under the curve (AUC) increase (i) and ground (g) using the
trapezoid rule (representing GC variability and total GC
exposure, respectively) [35]. Participants who did not pro-
vide a morning sample (obtained between 05:00 and 10:00
a.m.) or with <8 h of sample collection were excluded from
the analyses.
Table 1 shows the characteristics of participants by
group. Of all characteristics, only antidepressant use and
gestational age were significantly different between the
groups. Although one-third of the mothers monitored at the
POP outpatient clinic reported increased stress, mothers
who sought consultation at the POP clinical were no dif-
ferent from the other mothers in HADS score or the
majority of other characteristics, including breast-milk GC
rhythm parameters. Therefore, all mother-infant pairs were
analyzed as one group, while considering gestational age
and antidepressant use as potential confounders. Subse-
quently, associations between breast-milk GC rhythm
parameters and IBQ scores or infant sleep were tested using
linear or logistic regression, as appropriate. Second, we
performed multivariate analyses correcting for a set of
potential confounders based on the literature (infant sex,
socio-economic status, and maternal stress) or statistical
impact (antidepressant use and gestational age) [23, 24, 26].
Results were presented as beta or odds ratio (OR) [95%
confidence interval (CI)]. A p value < 0.05 was considered
statistically significant.
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Results
Figure 1 shows the stepwise inclusion procedure for the
study. A total of 303 mothers were approached, of whom
110 gave written informed consent. Of these, 59 completed
the study. Main reasons for drop-out were switching to
formula feeding or withdrawal of consent. Mothers collected
on average 6 (range: 4–8) milk samples over a 24-h period.
GC concentrations in their breast milk are displayed in Table
2, demonstrating that both cortisol and cortisone were highly
dependent on collection time. Table 3 presents breast-milk
GC rhythm parameters, IBQ scores and sleep outcomes.
Tables 4 and 5 present the multivariate associations
between breast-milk GC rhythm parameters, and infant
behavior and sleep. There were no associations between GC
rhythm parameters and infant behavior, except for a positive
association between breast-milk cortisol AUCg and infant
soothability (β= 0.15 [0.02–0.29], p < 0.05). Furthermore,
there were no associations between GC rhythm parameters
and infant sleep, except for a positive association between
breast-milk delta cortisone and infant sleep at night-time (β
= 0.07 [0.01–0.20], p < 0.05).
Discussion
In this study, with few exceptions, no associations were
found between breast-milk GC rhythmicity at 1 month
postpartum and infant behavior or sleep at age 3 months.
Therefore, our study did not lend support to conclusions
from previous studies in animals and humans
[19, 20, 24, 25]. Importantly, breast-milk sampling in the
previous studies did not take the diurnal rhythm of breast-
milk GCs into account. Although some of these studies
corrected analyses for sampling time, [23, 24, 26] it has
previously been demonstrated that such correction cannot
account for variability in cortisol levels over time [27, 36].
In situations where only one sample has been obtained,
there is no doubt that variability in sampling time has a
major impact on the interpretation of HPA axis dynamics,
which may lead to false conclusions; e.g., an outcome might
be associated with the height of the cortisol level, whereas it
actually reflects sampling time [29].
Evidence from twin studies indicated that IBQ dimen-
sions were explained by both environmental factors (in
particular maternal behavior, such as fear behavior and
responsiveness in mother-infant interactions [37, 38]) and
genetic factors [39]. There is insufficient evidence as to
whether breast-milk GCs could, in addition to the very
substantial impact of maternal behavior, materially con-
tribute to infant behavioral traits. Using sound methodol-
ogy, clearly our findings showed that breast-milk GCs were
unrelated to the far majority of infant behavioral traits, with
few exceptions. Although it could not be excluded that
exposure to breast-milk GCs positively affects infant sleep
or soothability, the small number of statistically significant
associations among 80 comparisons (2.5%) strongly sug-
gests that these might be explained by chance.
There is some evidence suggesting that breast-milk GCs
influence infant neurodevelopment in a sex-specific manner.
Among Rhesus monkeys, the associations between higher
milk cortisol levels and more nervous, less confident tem-
perament in offspring differed between males and females in
such a way that male offspring appeared to be more sensitive
to cortisol increments over time and female offspring to the
absolute cortisol concentration [20]. In humans, milk cortisol
was positively associated with negative affectivity among
girls, but not among boys [24, 26]. This might be attributed
to differences in the developmental timing of GC sensitivity
between males and females. Indeed, studies in rodents
showed that forebrain and hippocampal GC receptor
expression patterns developed in a sex-specific manner
[22, 40, 41]. Due to the small sample size in our study, we
were unable to perform sex-specific analyses.
This study has several strengths. It is the first to assess
the association between GC diurnal rhythmicity in breast
milk, and infant behavior and sleep. Moreover, measure-
ment of cortisone along with cortisol in breast milk carries
the advantage of having a more precise estimate of GC
exposure. Epithelial tissues have been demonstrated to
harbor 11β HSD type 2, which converts cortisol into cor-
tisone upon entrapment [42]. Consequently, cortisone may
Table 1 Maternal and infant characteristics by groupa
Maternal characteristics Group 1b (n= 42) Group 2c (n= 17)
Maternal age (years) 33.6 ± 4.7 31.6 ± 4.7
Maternal BMI (kg/m2) 22.3 ± 2.8 22.9 ± 2.2
Social economic statusd 0.6 ± 1.2 0.4 ± 1.3
Caucasian ethnicity 34 (81) 15 (88)
Primiparity 23 (55) 7 (41)
Selective antidepressant use 0 12 (71)*
HAS/HDS score ≥8 at 1 mo. pp (n= 58)e 6 (15) 6 (35)
Infant characteristics
Male sex 25 (60) 11 (65)
Birth weight (grams) 3,389 ± 439 3,561 ± 498
Gestational age (weeks) 39.1 ± 1.1 39.9 ± 1.3*
Vaginal birth (n= 58)e 20 (49) 13 (77)
≥80% breast milk at age 3 mo. (n= 58)e 37 (90) 14 (82)
*p < 0.05
aValues are presented as mean ± SD or n (%)
bMothers included at the maternity ward of the Amsterdam UMC
cMothers included at the Psychiatry Obstetric Pediatric (POP) exp ert
center of the OLVG hospital
dZ-score based on average income, % low-income, % low-skilled, and
% unemployed civilians per postal code area, based on data from the
Dutch Social Cultural Project office
eOne mother in group 1 did not provide these data
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be a more accurate marker of the circulating cortisol level
than cortisol itself, at least in saliva and hair [42–44]. This is
corroborated by observations demonstrating that cortisone
is less likely to have concentrations below the lower limit of
quantification at the nadir [34]. Moreover, the presence of
11β-reductase activity, necessary for the conversion of
cortisone to cortisol, in infants implies that ingested corti-
sone may become part of the biologically available GC pool
[36, 45]. Another strength of our study is the use of LC-MS/
MS, which has greater specificity than immunoassay [46] as
used by previous studies.
However, this study also has its limitations. First, the
sample size of our study, although comparable to previous
studies in this field [23–26], might have been too small to
detect subtle differences or to stratify for sex. However, this
limitation must be balanced against having multiple mea-
surements across the diurnal cycle. Second, we cannot
exclude the possibility that distressed mothers were less
likely to participate. Nonparticipants did not sign informed
consent, and nonresponse analyses could therefore not be
performed. This might offer an explanation for the obser-
vation that experienced maternal stress did not differ
between the groups. Third, in view of the limited number of
participants, it was not possible to correct for all potential
confounders, such as parental temper and other environ-
mental factors that might interfere with infant behavior or
sleep. Fourth, infant temperament and sleep were self-
reported by the mothers, and parenting behavior was not
assessed at all. Even though behavior is still thought to be
best reported by the infant’s primary caregiver, distressed
mothers may rate their infant’s behavior as more difficult
[47–49], To account for this phenomenon, all outcomes
were corrected for elevated HADS score [50, 51].
In conclusion, in our study breast-milk GC rhythmicity at
1 month postpartum was not associated with infant behavior
or sleep at 3 months postpartum. Therefore, this study
suggests that findings from previous studies linking breast-
milk cortisol to infant neurodevelopment might be biased
by the lack of GC measurements across the full
diurnal cycle.
Table 2 Breast-milk GC concentrations by collection time
Collection
time (h)
Number of
milk samples
Cortisol
(nmol/L)a
Cortisone
(nmol/L)a
02:00–06:00 39 4.5
(1.9–10.0)
19.6 (11.4–30.0)
6:00–10:00 83 9.6
(4.9–15.2)
32.5 (22.6–38.9)
10:00–14:00 80 4.0 (2.4– 5.8) 22.0 (16.5–27.1)
14:00–18:00 72 2.1 (1.4–3.3) 15.9 (10.8–20.4)
18:00–22:00 68 1.1 (0.7–1.8) 9.3 (5.8–11.9)
22:00–02:00 53 1.0 (0.5–1.9) 7.0 (4.6–14.8)
aConcentrations are presented as median (interquartile range)
Gave written informed 
consent (n=110) 
Completed sample 
collection one month 
postpartum (n=63) 
Completed assessment 
at three months 
postpartum (n=60)
Included in final analyses 
(n=59) 
Approached (n=303) 
1. Did not want to participate (n=106) 
2. Lost to follow-up (n=38) 
3. Did not meet inclusion criteria (n=49) 
a) Switched to formula feeding (n=32) 
b) Other reason (n=17)
1. Withdrew consent (n=12) 
2. Lost to follow-up (n=5) 
3. Excluded (n=30) 
a) Switched to formula feeding (n=18) 
b) Other reason (n=12) 
1. Withdrew consent (n=1) 
2. Lost to follow-up (n=2) 
1. Had not collected a milk sample between 
05:00-10:00 am and/or had <8h of sample 
collection (n=1)
Fig. 1 Flow chart of the
inclusion of mother-infant pairs
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Table 3 Measurements by
groupa
Group 1b (n= 42) Group 2c (n= 17) Total (n= 59)
Breast-milk GC rhythm parameters
Cortisol maximum (nmol/L) 15.8 ± 8.9 (9.2–20.8) 13.6 ± 8.2 (8.8–16.7) 15.2 ± 8.7 (9.2–19.2)
Average time of maximum 8:15 h 6:45 h 7:45 h
Δcortisol (nmol/L) 14.7 ± 9.0 (8.0–19.0) 12.5 ± 8.3 (8.3–16.0) 14.2 ± 8.8 (8.1–18.4)
AUCi/h of cortisol in 24 h 4.1 ± 2.3 (2.6–5.0) 3.0 ± 1.5 (1.9–3.8) 3.7 ± 2.2 (2.2–4.7)
AUCg/h of cortisol in 24 h 5.2 ± 2.4 (3.6–6.2)* 3.7 ± 1.5 (2.5–4.7) 4.8 ± 2.3 (3.3–5.8)
Cortisone maximum (nmol/L) 36.0 ± 10.6 (27.7–42.7) 33.8 ± 9.0 (26.6–40.2) 35.3 ± 10.1 (27.4–42.3)
Average time of maximum 08:00 h 8:30 h 8:15 h
Δcortisone (nmol/L) 28.9 ± 10.1 (23.5–35.6) 27.8 ± 8.7 (22.8–32.2) 28.6 ± 9.7 (23.3–34.2)
AUCi/h of cortisone in 24 h 12.2 ± 4.4 (10.0–14.9) 10.8 ± 4.4 (8.0–14.5) 11.8 ± 4.4 (9.4–14.7)
AUCg/h of cortisone in 24 h 19.2 ± 5.7 (16.0–21.8) 16.8 ± 4.5 (13.2–19.8) 18.5 ± 5.4 (14.8–21.1)
IBQ domains
Activity 3.2 ± 0.9 3.0 ± 0.7 3.1 ± 0.9
Distress to limitations 3.3 ± 0.9 3.2 ± 0.9 3.3 ± 0.9
Approach to novel stimuli 2.0 ± 1.0 2.1 ± 0.7 2.0 ± 0.9
Duration of orienting 3.6 ± 1.2 4.0 ± 0.9 3.7 ± 1.2
Smiling and laughter 4.3 ± 1.0 4.5 ± 1.0 4.4 ± 1.0
Soothability 5.0 ± 1.2 4.9 ± 1.1 5.0 ± 1.1
Infant sleep parameters
Hours of night-time sleep 8.2 ± 2.3 8.6 ± 2.3 8.3 ± 2.3
Hours of daytime sleep 4.3 ± 1.9 4.5 ± 1.6 4.4 ± 1.8
Number of naps during
daytime (n= 58)
3.3 ± 0.8 3.3 ± 1.1 1.5 ± 1.0
Number of nights per week
with >6 h sleep
4.1 ± 3.0 4.4 ± 2.7 4.2 ± 2.9
IBQ Infant Behavior Questionnaire
*p < 0.05
aValues are presented as mean ± SD (range). Maximum=Maximum concentration measured. Δ=
Difference between the maximum and the minimum concentration. AUCi/h=Area under the curve
increase per hour collection. AUCg/h=Area under the curve ground per hour collection. Groups were
compared using the independent samples t test
bMothers included at the maternity ward of the Amsterdam UMC
cMothers included at the Psychiatry Obstetric Pediatric (POP) expert center of the OLVG hospital
Table 4 Associations between breast-milk cortisol rhythm parameters and infant behavior and sleepa
IBQ domains Maximum cortisol
(nmol/L)
Δcortisol
(nmol/L)
Cortisol AUCi/h
(in 24 h)
Cortisol AUCg/h
(in 24 h)
Distress to limitations −0.02 (−0.05 to 0.01) −0.02 (−0.04 to 0.01) −0.02 (−0.13 to 0.09) −0.03 (−0.13 to 0.08)
Approach to novel stimuli −0.02 (−0.05 to 0.01) −0.02 (−0.05 to 0.01) −0.05 (−0.16 to 0.06) −0.03 (−0.13 to 0.07)
Soothability 0.02 (−0.02 to 0.04) 0.02 (−0.02 to 0.05) 0.13 (−0.02 to 0.27) 0.15 (0.02 to 0.28)*
Smiling and laughter 0.01 (−0.02 to 0.04) 0.01 (−0.02 to 0.04) 0.005 (−0.11 to 0.12) 0.02 (−0.10 to 0.13)
Duration of orienting −0.004 (−0.04 to 0.03) −0.01 (−0.05 to 0.03) −0.04 (−0.19 to 0.11) 0.03 (−0.11 to 0.17)
Activity 0.01 (−0.02 to 0.04) 0.01 (−0.02 to 0.03) 0.02 (−0.09 to 0.13) 0.05 (−0.05 to 0.15)
Infant sleep parameters
Hours of night-time sleep 0.04 (−0.03 to 0.11) 0.05 (−0.02 to 0.12) 0.07 (−0.22 to 0.35) −0.03 (−0.29 to 0.23)
Hours of daytime sleep 0.01 (−0.05 to 0.07) 0.01 (−0.05 to 0.07) 0.01 (−0.23 to 0.25) 0.01 (−0.23 to 0.22)
Number of nights per week with >6 h sleepb (0–4 days= 0, 5–7 days= 1) 0.98 (0.92–1.04) 0.98 (0.92–1.05) 0.92 (0.71–1.20) 0.87 (0.67–1.12)
Number of naps during daytimeb (<3 naps= 0, ≥3 naps= 1) 0.93 (0.86–1.01) 0.94 (0.88–1.02) 0.87 (0.66–1.15) 0.77 (0.57–1.04)
*p < 0.05
aValues are presented as beta (95% CI) and adjusted for infant sex, socio-economic status, elevated HADS score at 1 mo. pp (HAS/HDS score ≥8),
use of antidepressants and gestational age
bOR. Maximum=Maximum concentration measured. Δ=Difference between the maximum and the minimum concentration. AUCi/h=Area
under the curve increase per hour collection. AUCg/h=Area under the curve ground per hour collection
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